Cartesian Therapeutics Inc (RNAC)

Nov 03, 2025

Cartesian Therapeutics Inc expected to post a loss of 84 cents a shareEarnings Preview - TradingView

Nov 03, 2025

Nov 03, 2025

Is a relief rally coming for Cartesian Therapeutics Inc. holdersJuly 2025 Momentum & Stepwise Entry/Exit Trade Alerts - newser.com

Nov 03, 2025

Nov 03, 2025

How Cartesian Therapeutics Inc. (1S70) stock expands through international marketsWeekly Investment Report & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 03, 2025

Nov 03, 2025

Is Cartesian Therapeutics Inc. trending in predictive chart modelsQuarterly Portfolio Review & Weekly Hot Stock Watchlists - newser.com

Nov 03, 2025

Nov 03, 2025

Key metrics from Cartesian Therapeutics Inc.’s quarterly dataPortfolio Update Summary & Consistent Profit Trading Strategies - newser.com

Nov 03, 2025

Nov 03, 2025

How Cartesian Therapeutics Inc. stock performs during Fed tightening cyclesDay Trade & AI Forecasted Entry/Exit Points - newser.com

Nov 03, 2025

Nov 03, 2025

What makes Cartesian Therapeutics Inc. (1S70) stock appealing to growth investorsJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - newser.com

Nov 03, 2025

Nov 03, 2025

Is Cartesian Therapeutics Inc. a candidate for recovery playTrade Volume Summary & AI Enhanced Trading Alerts - newser.com

Nov 03, 2025

Nov 02, 2025

Will Cartesian Therapeutics Inc. price bounce be sustainableVolume Spike & Daily Growth Stock Tips - newser.com

Nov 02, 2025

Nov 02, 2025

How to read the order book for Cartesian Therapeutics Inc.2025 Market WrapUp & Community Trade Idea Sharing - newser.com

Nov 02, 2025

Nov 01, 2025

Will Cartesian Therapeutics Inc. stock outperform tech sector in 2025Entry Point & High Conviction Buy Zone Picks - newser.com

Nov 01, 2025

Nov 01, 2025

Working capital per share of Cartesian Therapeutics, Inc. – FWB:1S70 - TradingView

Nov 01, 2025

Nov 01, 2025

Is Cartesian Therapeutics Inc. stock near bottom after declineWeekly Risk Summary & Short-Term Swing Trade Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Combining price and volume data for Cartesian Therapeutics Inc.Quarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com

Nov 01, 2025

Nov 01, 2025

Is Cartesian Therapeutics Inc. stock supported by strong fundamentalsJuly 2025 Setups & Daily Volume Surge Trade Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Will Cartesian Therapeutics Inc. (1S70) stock gain from green policiesBear Alert & Verified Trade Idea Suggestions - newser.com

Nov 01, 2025

Oct 31, 2025

Cartesian Therapeutics, Inc. (RNAC) Analyst insights, Price targets and Recommendations - Yahoo! Finance Singapore

Oct 31, 2025

Oct 31, 2025

Cartesian Therapeutics (RNAC) Expected to Announce Earnings on Thursday - MarketBeat

Oct 31, 2025

Oct 31, 2025

Cartesian Therapeutics Announces Leadership Changes - The Globe and Mail

Oct 31, 2025

Oct 31, 2025

Ranking Cartesian Therapeutics Inc. among high performing stocks via tools2025 Momentum Check & Safe Investment Capital Preservation Plans - newser.com

Oct 31, 2025

Oct 31, 2025

What indicators show strength in Cartesian Therapeutics Inc.Portfolio Risk Summary & Daily Volume Surge Signals - newser.com

Oct 31, 2025

Oct 30, 2025

Cartesian Therapeutics Appoints Carsten Brunn, Ph.D., as Board Chairman - citybiz

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics, Inc. Announces Board and Committee Changes, Effective from October 29, 2025 - MarketScreener

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics (RNAC) Grants Stock Options to New Employ - GuruFocus

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics Advances SLE Treatment with Descartes-08 Study - MSN

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants - The Manila Times

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics Announces Carsten Brunn, Ph.D., Named as Chairman of the Company’s Board of Directors - The Manila Times

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics Announces Board Changes - TradingView

Oct 30, 2025

Oct 30, 2025

[8-K] Cartesian Therapeutics, Inc. Reports Material Event | RNAC SEC FilingForm 8-K - Stock Titan

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics (NASDAQ: RNAC) grants options at $8.85 and $8.20 inducement - Stock Titan

Oct 30, 2025

Oct 30, 2025

Cartesian Therapeutics (NASDAQ: RNAC) appoints CEO Carsten Brunn as chairman - Stock Titan

Oct 30, 2025